Form 483

Pace Analytical Life Sciences, LLC Form 483, 2018-02-07

FDA issued a Form 483 to Pace Analytical Life Sciences, LLC on 2018-02-07 with 3 public-safe observations.

483· Form 483 issuedHuman Drugs3 observations

Pace Analytical Life Sciences, LLC · Oakdale, United States · Issued February 7, 2018

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

7 Feb 2018
21 CFR 211.194(a)

Complete test data included in records

Cited by Scott A Golladay

7 Feb 2018
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Scott A Golladay

7 Feb 2018
21 CFR 211.68(a)

Calibration/Inspection/Checking not done

Cited by Scott A Golladay

Inspected site

PAPace Analytical Life Sciences, LLCOakdale, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.194(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 3 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere